Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04044664 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder
A Phase 2 study, sponsored by Aptinyx.
- Completed
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
NCT04044664 is a Phase 2 study that has completed, run by Aptinyx. The registered enrollment target is 160 participants.
The verdict
NCT04044664, a Phase 2 study, has completed, sponsored by Aptinyx.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
Study Summary
To evaluate the safety, tolerability, and response profile of NYX-783 in a Post-Traumatic Stress Disorder population.
Interventions
- DRUG Placebo oral capsule
- DRUG NYX-783
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2020-08-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04044664
The ClinicalTrials.gov registry entry for NCT04044664 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aptinyx, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT04044664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04044664 about?
NCT04044664 is a clinical study titled "Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder". To evaluate the safety, tolerability, and response profile of NYX-783 in a Post-Traumatic Stress Disorder population.
What is the current status of trial NCT04044664?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2019-01-25. Estimated completion is 2020-08-05.
What interventions are being tested in trial NCT04044664?
The interventions under investigation include: Placebo oral capsule (DRUG), NYX-783 (DRUG).
Who is sponsoring clinical trial NCT04044664?
This trial is sponsored by Aptinyx, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.